Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells
Open Access
- 21 December 2021
- journal article
- Published by IOS Press in Tumor Biology
- Vol. 43 (1), 327-340
- https://doi.org/10.3233/tub-211515
Abstract
BACKGROUND: The inhibition of the enzyme telomerase (TERT) has been widely investigated as a new pharmacological approach for cancer treatment, but its real potential and the biochemical consequences are not totally understood. OBJECTIVE: Here, we investigated the effects of the telomerase inhibitor MST-312 on a human glioma cell line after both short- and long-term (290 days) treatments. METHODS: Effects on cell growth, viability, cell cycle, morphology, cell death and genes expression were assessed. RESULTS: We found that short-term treatment promoted cell cycle arrest followed by apoptosis. Importantly, cells with telomerase knock-down revealed that the toxic effects of MST-312 are partially TERT dependent. In contrast, although the long-term treatment decreased cell proliferation at first, it also caused adaptations potentially related to treatment resistance and tumor aggressiveness after long time of exposition. CONCLUSIONS: Despite the short-term effects of telomerase inhibition not being due to telomere erosion, they are at least partially related to the enzyme inhibition, which may represent an important strategy to pave the way for tumor growth control, especially through modulation of the non-canonical functions of telomerase. On the other hand, long-term exposure to the inhibitor had the potential to induce cell adaptations with possible negative clinical implications.Keywords
This publication has 39 references indexed in Scilit:
- Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer CellsPLOS ONE, 2014
- Novel anticancer therapeutics targeting telomeraseCancer Treatment Reviews, 2013
- Histone methyltransferase Suv39h1 deficiency prevents Myc‐induced chromosomal instability in murine myeloid leukemiasGenes, Chromosomes and Cancer, 2013
- Detection of alternative lengthening of telomeres by telomere quantitative PCRNucleic Acids Research, 2012
- Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in CancerCell, 2012
- Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic MechanismsPLOS ONE, 2011
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- The effects of telomerase inhibition on prostate tumor‐initiating cellsInternational Journal of Cancer, 2009
- Suv4-20h deficiency results in telomere elongation and derepression of telomere recombinationThe Journal of cell biology, 2007
- Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferasesNature Genetics, 2003